A A. Kadar ( Department of ENT, Jinnah Postgraduate Medical Centre, Karachi. )
M. A. Obaid ( Department of ENT, Jinnah Postgraduate Medical Centre, Karachi. )
September 2003, Volume 53, Issue 9
Original Article
Introduction
There are numerous studies in which a local anaesthetic has been applied to the tonsillar fossae after tonsillectomy either by infiltration or topical spray. There are risks with infiltration technique such as accidental intravascular injection leading to life threatening arrhythmias. Life threatening upper airway obstruction after infiltration of bupivacaine has been reported in children.2 Visual loss3, cervical osteomyelitis4 and bilateral vocal cord paralysis5 has been associated with local infiltration.
In the study, we used Abbocaine (bupivacaine by Abbott Laboratories) soaked tonsillar pack applied to tonsillar fossa for 5 minutes, as a safer and reliable alternative to local infiltration.
Patients and Methods
Results
There was significant difference between subject and control fossae scores at all the stages up to discharge of patients (Table, Figures 1-5). None of the seventy two patients had any complication related to bupivacaine.
Discussion
Pain is a subjective and complex expression depending on factors such as age, social and ethnic background, anxiety level, personal experience, perceptual abilities and the ability to describe pain based on certain frames of references. Pain questionnaires and pain scales have been used to categorize and quantify pain experience, however, the visual analogue score (VAS) has shown to be both realistic and reproducible.6 The absolute visual analogue scores can be difficult to interpret, but when focusing mainly on the repeated measures in the same patients, interpretable comparisons between different stages can be made.
The efficacy of local bupivacaine application in post-tonsillectomy pain has been extensively studied.7-18 Some recent studies19-21 have shown that use of bupivacaine has no role in relieving post-tonsillectomy pain, however, scores of studies have shown the efficacy of bupivacaine in relieving post-tonsillectomy pain. Bupivacaine is an amide- linked local analgesic. It was synthesized by Ekenstan in 1957 and has been used extensively in obstetric practice to produce epidural analgesia and peripheral nerve blockade in the management of intractable pain. Its high lipid solubility and protein binding results in rapid onset of action and prolonged duration (6-9 hours). Bupivacaine 0.5% needs to be in contact with a raw area for about 10 seconds to be effective.22 The recommended upper limit of safe dosage of bupivacaine is 2mg/kg body weight.23 This is equivalent to 25-30 ml of 0.5% solution. Systemic toxicity produces arrhythmia, drowsiness, convulsions, paraesthesia, disorientation and nystagmus.
In our study we chose to use tonsillar swab soaked in bupivacaine kept in tonsillar fossa for 5 minutes because we believe this to be a safer alternative to topical infiltration.
This study convincingly demonstrates that topical application of bupivacaine in tonsillar fossa after surgery, reduces post-operative pain at all stages of the trial up to the discharge of the patients. Although the local effect of bupivacaine can last only for 6-9 hours, we have noticed in our study and also seen in other trials10,24,25 that analgesia effects last beyond the expected duration of the local anaesthesia. This protracted pain relief resulting by a single use of bupivacaine cannot be explained by prolonged presence of the local anaesthetic in the area of surgery. An explanation for this long lasting pain relief might be that neural blockade prevents nociceptive impulses from entering the central nervous system during and immediately after surgery and this suppresses formation of the sustained hyperexcitable state responsible for the maintenance of post-operative pain. Local anaesthetic induces the antinociceptive effect by acting on the nerve membranes; however, these affect many membrane-associated proteins in any tissue. They can inhibit the release and action of agents (prostaglandins, lysosomal enzymes, etc.) sensitizing or stimulating the nociceptors and participating in inflammation.26
In conclusion, topical application of bupivacaine to the tonsillar fossa can reduce post-operative pain and facilitate eating and drinking during the post-operative period. We suggest that any procedure resulting in shorter hospitalization time, rapid recovery and smooth convalescence should be employed.
Acknowledgements
Conclusion
References
2. Bean-Lijewski JD. Glossopharyngeal nerve block for pain relief after paediatric tonsillectomy: retrospective analysis and two cases of life-threatening upper airway obstruction from an interrupted trial. Aesth Analg 1997;84:1232-8.
3. Ellis P. Visual loss following tonsillectomy. Arch Otolaryngol Head Neck Surg 1968; 87:436-8.
4. Cyna AM, Bell KR, Flood LM. Cervical osteomyelitis after tonsillectomy. Anaesthesia 1997;52:1084-7.
5. Weksler N, Nash M, Rozentsveig V, et al. Vocal cord paralysis as a consequence of peritonsillar infiltration with bupivacaine. Acta Anaesthesiol Scand 2001;45:1042-4.
6. Huskisson EC. Measurement of pain. Lancet 1974;21:1127-31.
7. Alvarez Garcia MV, Santaolalla Fragoso B, Cerbrian Pazos J, et al. Intraoperative infiltration of 0.5% bupivacaine in paediatric tonsillectomy. Acta Otorinolaringol Esp 1997;48:287-90.
8. Wong AK, Bissonnette B, Braude BM, et al. Post-tonsillectomy infiltration with bupivacaine reduces immediate postoperative pain in children. Can J Anaesth 1995; 42:770-4.
9. Melchor MA, Villafruela MA, Munoz B, et al. Postopertive pain in tonsillectomy in general anaesthesia and local infiltration. Acta Otorinolaringol Esp 1994;45:349-55.
10. Jebels JA, Reilly JS, Guiterrez JF, et al. The effect of pre-incisional infiltration of tonsils with bupivacaine on the pain following tonsillectomy under general anaesthesia. Pain 1999;47:305-8.
11. Broadman LM, Patel RI, Feldman BA, et al. The effect of peritonsillar infiltration on the reduction of intraoperative blood loss and post-tonsillectomy pain in children. Laryngoscope 1989;99:578-81.
12. Strubb KA, Tschopp K, Frei F, et al. Local infiltration of epinephrine and bupivacaine before tonsillectomy. HNO 1996;44:672-6.
13. Stuart JC, MacGregor FB, Cairns CS, et al. Peritonsillar infiltration with bupivacaine for paediatric tonsillectomy. Anaesth Intensive Care 1994;22:679-82.
14. Warnock FF, Lander J. Pain progression, intensity and outcomes following tonsillectomy. Pain 1998;75:37-45.
15. Molliex S, Haond P, Baylot D, et al. Effect of pre-versus postoperative tonsillar infiltration with local anaesthetics on postoperative pain after tonsillectomy. Acta Anaesthesiol Scand 1996;40:1210-15.
16. Nordahl SH, Albrektsen G, Guttormsen AB, et al. Effect of bupivacaine on pain after tonsillectomy. Acta Otolaryngol 1999;119:369-76.
17. Orntoft S, Longreen A, Moiniche S, et al. A comparison of pre and postoperative tonsillar infiltration with bupivacaine on pain after tonsillectomy. Anaesthesia 1994; 49:151-4.
18. Hung T, Moore-Gillon V, Hern J, et al. Topical bupivacaine in paediatric day-case tonsillectomy: a prospective randomized controlled trial. J Laryngol Otol. 2002;116:33-6.
19. Kountakis SE. Effectiveness of perioperative bupivacaine infiltration in tonsillectomy patients. Am J Otolaryngol 2002;23:76-80.
20. Vasan NR, Stevenson S, Ward M. Preincisional bupivacaine in posttonsillectomy pain relief: a randomized prospective study. Arch Otolaryngol Head Neck Surg 2002;128:145-9.
21. El-Hakim H, Nunez DA, Saleh HA, et al. A randomised controlled trial of the effect of regional nerve blocks on immediate post-tonsillectomy pain in adult patients. Clin Otolaryngol. 2000;25:413-17.
22. Cook JH. Bupivacaine squirting. Ann Royal Coll Surg Engl 1987;69:4.
23. Martindale The Extra Pharmacopoeia. The Pharmaceutical Press, London: 1982, pp. 910-12.
24. Patel JM, Lanzafame RJ, Williams JS, et al. The effect of inciosional infiltration of bupivacaine hydrochloride upon pulmonary functions, atelectasis and narcotic need following elective cholecystectomy. Surg Gynecol Obstet 1983;157:338-40.
25. Tverskoy M, Cozacov C, Ayache M, et al. Postoperative pain after inguinal herniorraphy with different types of anaesthesia. Anaesth Analg 1990;70:29-35.
26. Butterworth JF, Strichartz GR, Molecular mechanisms of local anaesthesia: a review. Anesthesiology 1990;72:711-34.
Abstract
Objective:
To assess the effect on postoperative pain after local application of bupivacaine in the tonsillar fossa.
Methods:
Seventy two patients were recruited in this prospective single blind controlled trial. There were 45 females and 27 males between the ages of 7 and 35 years. After tonsillectomy the right tonsillar fossae (subject fossae) were packed with tonsillar gauze soaked in 2mls of 0.5 % Abbocaine (bupivacaine) solution and kept in situ for five minutes. The left fossae (control fossae) were packed with the similar tonsillar swab soaked in 0.9 % normal saline.
Results:
The main outcome measure was severity of pain by using visual analogue score. The measurements were taken at various intervals, i.e. after 4 hours, before bed, before breakfast, before lunch and before discharge. The mean post-operative pain scores for the subject fossa after 4 hours, before bed, before breakfast, before lunch and before discharge were 3.09 (± 0.85), 3.25 (± 0.64), 2.89 (± 0.72), 2.47 (± 0.67) and 2.37 (± 0.57) respectively. The mean post-operative pain scores for control fossa after 4 hours, before bed, before breakfast, before lunch and before discharge were 5.78 (± 1.51), 5.50 (± 1.29), 4.34 (± 1.13), 3.29 (± 0.91) and 2.73 (± 0.81) respectively. There was significant difference between subject and control fossae scores at all the stages up to discharge of patients, showing better pain relief with bupivacaine.
Conclusion:
Topical application of bupivacaine to the tonsillar fossa can reduce post-operative pain and facilitate early eating and drinking during the post-operative period (JPMA 53:422;2003).
To assess the effect on postoperative pain after local application of bupivacaine in the tonsillar fossa.
Methods:
Seventy two patients were recruited in this prospective single blind controlled trial. There were 45 females and 27 males between the ages of 7 and 35 years. After tonsillectomy the right tonsillar fossae (subject fossae) were packed with tonsillar gauze soaked in 2mls of 0.5 % Abbocaine (bupivacaine) solution and kept in situ for five minutes. The left fossae (control fossae) were packed with the similar tonsillar swab soaked in 0.9 % normal saline.
Results:
The main outcome measure was severity of pain by using visual analogue score. The measurements were taken at various intervals, i.e. after 4 hours, before bed, before breakfast, before lunch and before discharge. The mean post-operative pain scores for the subject fossa after 4 hours, before bed, before breakfast, before lunch and before discharge were 3.09 (± 0.85), 3.25 (± 0.64), 2.89 (± 0.72), 2.47 (± 0.67) and 2.37 (± 0.57) respectively. The mean post-operative pain scores for control fossa after 4 hours, before bed, before breakfast, before lunch and before discharge were 5.78 (± 1.51), 5.50 (± 1.29), 4.34 (± 1.13), 3.29 (± 0.91) and 2.73 (± 0.81) respectively. There was significant difference between subject and control fossae scores at all the stages up to discharge of patients, showing better pain relief with bupivacaine.
Conclusion:
Topical application of bupivacaine to the tonsillar fossa can reduce post-operative pain and facilitate early eating and drinking during the post-operative period (JPMA 53:422;2003).
Related Articles
Journal of the Pakistan Medical Association has agreed to receive and publish manuscripts in accordance with the principles of the following committees:




